These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 22142351

  • 1. Carvedilol reduces aortic wave reflection and improves left ventricular/vascular coupling: a comparison with atenolol (CENTRAL Study).
    Shah NK, Smith SM, Nichols WW, Lo MC, Ashfaq U, Satish P, Johnson JA, Epstein BJ.
    J Clin Hypertens (Greenwich); 2011 Dec; 13(12):917-24. PubMed ID: 22142351
    [Abstract] [Full Text] [Related]

  • 2. Different patterns of peripheral versus central blood pressure in hypertensive patients treated with β-blockers either with or without vasodilator properties or with angiotensin receptor blockers.
    Polónia J, Barbosa L, Silva JA, Bertoquini S.
    Blood Press Monit; 2010 Oct; 15(5):235-9. PubMed ID: 20577082
    [Abstract] [Full Text] [Related]

  • 3. The vasodilatory beta-blockers.
    Pedersen ME, Cockcroft JR.
    Curr Hypertens Rep; 2007 Aug; 9(4):269-77. PubMed ID: 17686376
    [Abstract] [Full Text] [Related]

  • 4. Comparison of a new vasodilating beta-blocker, carvedilol, with atenolol in the treatment of mild to moderate essential hypertension.
    Ruilope LM.
    Am J Hypertens; 1994 Feb; 7(2):129-36. PubMed ID: 7910028
    [Abstract] [Full Text] [Related]

  • 5. A comparison of carvedilol with atenolol in the treatment of mild-to-moderate essential hypertension. INT-CAR-07 (U.K.) Study Group.
    Young PH.
    J Cardiovasc Pharmacol; 1992 Feb; 19 Suppl 1():S82-5. PubMed ID: 1378155
    [Abstract] [Full Text] [Related]

  • 6. Metabolic and cardiovascular effects of carvedilol and atenolol in non-insulin-dependent diabetes mellitus and hypertension. A randomized, controlled trial.
    Giugliano D, Acampora R, Marfella R, De Rosa N, Ziccardi P, Ragone R, De Angelis L, D'Onofrio F.
    Ann Intern Med; 1997 Jun 15; 126(12):955-9. PubMed ID: 9182472
    [Abstract] [Full Text] [Related]

  • 7. A comparison of the two beta-blockers carvedilol and atenolol on left ventricular ejection fraction and clinical endpoints after myocardial infarction. a single-centre, randomized study of 232 patients.
    Jonsson G, Abdelnoor M, Müller C, Kjeldsen SE, Os I, Westheim A.
    Cardiology; 2005 Jun 15; 103(3):148-55. PubMed ID: 15785019
    [Abstract] [Full Text] [Related]

  • 8. Safety and antihypertensive efficacy of carvedilol and atenolol alone and in combination with hydrochlorothiazide.
    Widmann L, van der Does R, Hörrmann M, Machwirth M.
    Eur J Clin Pharmacol; 1990 Jun 15; 38 Suppl 2():S143-6. PubMed ID: 1974505
    [Abstract] [Full Text] [Related]

  • 9. Efficacy of carvedilol in mild to moderate essential hypertension and effects on microalbuminuria: a multicenter, randomized, open-label, controlled study versus atenolol.
    Marchi F, Ciriello G.
    Adv Ther; 1995 Jun 15; 12(4):212-21. PubMed ID: 10155349
    [Abstract] [Full Text] [Related]

  • 10. Blood pressure lowering efficacy of dual alpha and beta blockers for primary hypertension.
    Wong GW, Laugerotte A, Wright JM.
    Cochrane Database Syst Rev; 2015 Aug 26; 2015(8):CD007449. PubMed ID: 26306578
    [Abstract] [Full Text] [Related]

  • 11. Different aortic reflection wave responses following long-term angiotensin-converting enzyme inhibition and beta-blocker in essential hypertension.
    Pannier BM, Guerin AP, Marchais SJ, London GM.
    Clin Exp Pharmacol Physiol; 2001 Dec 26; 28(12):1074-7. PubMed ID: 11903319
    [Abstract] [Full Text] [Related]

  • 12. Beta-blockers reduce aortic stiffness in hypertension but nebivolol, not atenolol, reduces wave reflection.
    Mahmud A, Feely J.
    Am J Hypertens; 2008 Jun 26; 21(6):663-7. PubMed ID: 18437130
    [Abstract] [Full Text] [Related]

  • 13. β-blockers: a review of their pharmacological and physiological diversity in hypertension.
    Ripley TL, Saseen JJ.
    Ann Pharmacother; 2014 Jun 26; 48(6):723-33. PubMed ID: 24687542
    [Abstract] [Full Text] [Related]

  • 14. Carvedilol in hypertension treatment.
    Stafylas PC, Sarafidis PA.
    Vasc Health Risk Manag; 2008 Jun 26; 4(1):23-30. PubMed ID: 18629377
    [Abstract] [Full Text] [Related]

  • 15. Efficacy of losartan and carvedilol on central hemodynamics in hypertensives: a prospective, randomized, open, blinded end point, multicenter study.
    Kim EJ, Song WH, Lee JU, Shin MS, Lee S, Kim BO, Hong KS, Han SW, Park CG, Seo HS.
    Hypertens Res; 2014 Jan 26; 37(1):50-6. PubMed ID: 24026037
    [Abstract] [Full Text] [Related]

  • 16. Adrenoreceptors, endothelial function, and lipid profile: effects of atenolol, doxazosin, and carvedilol.
    González Maqueda I.
    Coron Artery Dis; 1994 Nov 26; 5(11):909-18. PubMed ID: 7719523
    [Abstract] [Full Text] [Related]

  • 17. Hemodynamic effects of carvedilol after acute oral administration in hypertensive and normal subjects.
    Cournot A, Lim C, Duchier J, Safar M.
    J Cardiovasc Pharmacol; 1992 Nov 26; 19 Suppl 1():S35-9. PubMed ID: 1378147
    [Abstract] [Full Text] [Related]

  • 18. Effects of third-generation β-blockers, atenolol or amlodipine on blood pressure variability and target organ damage in spontaneously hypertensive rats.
    Del Mauro JS, Prince PD, Allo MA, Santander Plantamura Y, Morettón MA, González GE, Bertera FM, Carranza A, Gorzalczany SB, Chiappetta DA, Morales C, Gelpi RJ, Taira CA, Polizio AH, Donato M, Höcht C.
    J Hypertens; 2020 Mar 26; 38(3):536-545. PubMed ID: 32028517
    [Abstract] [Full Text] [Related]

  • 19. Efficacy and safety of carvedilol in comparison with atenolol in hypertensive patients pretreated with hydrochlorothiazide.
    van der Does R, Widmann L, Uberbacher HJ, Hörrmann M, Machwirth M, Stienen U.
    Eur J Clin Pharmacol; 1990 Mar 26; 38 Suppl 2():S147-52. PubMed ID: 1974506
    [Abstract] [Full Text] [Related]

  • 20. Effects of carvedilol and atenolol on arterial pulse curves (plethysmography) and finger temperature after hand cooling.
    Klemsdal TO, Mundal HH, Gjesdal K.
    Eur J Clin Pharmacol; 1996 Mar 26; 50(6):483-9. PubMed ID: 8858276
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.